Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2011

01.03.2011 | Review Article

Disorders of glucose metabolism–post mortem analyses in forensic cases: part I

verfasst von: Cornelius Hess, Frank Musshoff, Burkhard Madea

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

In developed countries, diabetes is one of the ten most common causes of death. Post mortem diagnosis of glucose metabolism disorders can be difficult and vague because of the lack of characteristic morphological findings. Reviews of the literature are presented concerning biochemical problems in cases of unclear hyper- or hypoglycemia. After repetition of causes, frequency, and mortality of diabetic metabolism disorders, we give hints for the detection of diabetic ketoacidosis, hyperosmolar coma, insulinoma, and insulin- or oral diabetic-induced hypoglycemia. The first part discusses the analytes glucose and lactate, glycated proteins and oral antidiabetics, with special regard to their matrices post mortem, to reference concentrations, stability data and to analytic procedures that should be used in clinical or toxicological laboratories to detect diabetic metabolism disorders after death.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hess C, Musshoff F, Madea B (2010) Disorders of glucose metabolism – post mortem analyses in forensic cases – Part II. Int J Leg Med. Submitted Hess C, Musshoff F, Madea B (2010) Disorders of glucose metabolism – post mortem analyses in forensic cases – Part II. Int J Leg Med. Submitted
3.
Zurück zum Zitat Thomas L (2000) Labor und Diagnose. Indikationen und Bewertung von Laborbefunden für die medizinische Diagnostik. 5.erweiterte Auflage. TH Books, Frankfurt Thomas L (2000) Labor und Diagnose. Indikationen und Bewertung von Laborbefunden für die medizinische Diagnostik. 5.erweiterte Auflage. TH Books, Frankfurt
4.
Zurück zum Zitat Faber OK, Binder C (1986) C-peptide: an index of insulin secretion. Diabetes Metab Rev 2:331–345PubMed Faber OK, Binder C (1986) C-peptide: an index of insulin secretion. Diabetes Metab Rev 2:331–345PubMed
5.
Zurück zum Zitat Karam JH (2007) Pancreatic hormones and diabetes mellitus In: Greenspan FS, Gardner DG (ed.) Basic and Clinical Endocrinology 8th edn, chapter 18 Karam JH (2007) Pancreatic hormones and diabetes mellitus In: Greenspan FS, Gardner DG (ed.) Basic and Clinical Endocrinology 8th edn, chapter 18
6.
Zurück zum Zitat Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH (1992) Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diab Care 15:666–692 Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH (1992) Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diab Care 15:666–692
7.
Zurück zum Zitat Lehnert H, Schuster HP (1999) In: Innere Medizin. Thieme Verlag. pp 136–137 Lehnert H, Schuster HP (1999) In: Innere Medizin. Thieme Verlag. pp 136–137
8.
Zurück zum Zitat Marks V, Teale JD (1993) Hypoglycaemia in the adult. Baillières Clin Endocrinol Metab 7:705–729PubMed Marks V, Teale JD (1993) Hypoglycaemia in the adult. Baillières Clin Endocrinol Metab 7:705–729PubMed
9.
Zurück zum Zitat Butler PC, Rizza RA (1989) Regulation of carbohydrate metabolism and response to hypoglycemia. Endocrinol Metab Clin North Am 18:1–25PubMed Butler PC, Rizza RA (1989) Regulation of carbohydrate metabolism and response to hypoglycemia. Endocrinol Metab Clin North Am 18:1–25PubMed
10.
Zurück zum Zitat Nilsson A, Tideholm B, Kalen J, Katzman P (1988) Incidence of severe hypoglycemia and its causes in insulin-treated diabetics. Acta Med Scand 224:257–262PubMed Nilsson A, Tideholm B, Kalen J, Katzman P (1988) Incidence of severe hypoglycemia and its causes in insulin-treated diabetics. Acta Med Scand 224:257–262PubMed
11.
Zurück zum Zitat MacLeod KM, Hepburn DA, Frier BM (1993) Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 10:238–245PubMed MacLeod KM, Hepburn DA, Frier BM (1993) Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 10:238–245PubMed
12.
Zurück zum Zitat Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM (2006) 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila) 44:803–932 Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM (2006) 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila) 44:803–932
13.
Zurück zum Zitat Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE (2008) 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 46:927–1057 Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE (2008) 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 46:927–1057
14.
Zurück zum Zitat Hirsch IB (2005) Insulin analogues. N Engl J Med 352:174–183PubMed Hirsch IB (2005) Insulin analogues. N Engl J Med 352:174–183PubMed
15.
Zurück zum Zitat Rodriguez Perez C, Lizondo Escuder A, Lopez Garcia MJ, Escriva Cholbi L, Alpera Lacruz R, Collado Perez C (2008) A study of variability in glycaemia in children and adolescents with diabetes mellitus type 1 on treatment with insulin glargine. An Pediatr (Barc) 69:426–431 Rodriguez Perez C, Lizondo Escuder A, Lopez Garcia MJ, Escriva Cholbi L, Alpera Lacruz R, Collado Perez C (2008) A study of variability in glycaemia in children and adolescents with diabetes mellitus type 1 on treatment with insulin glargine. An Pediatr (Barc) 69:426–431
16.
Zurück zum Zitat Fletcher SM (1983) Insulin. A forensic primer. J Forensic Sci Soc 23:5–17PubMed Fletcher SM (1983) Insulin. A forensic primer. J Forensic Sci Soc 23:5–17PubMed
17.
Zurück zum Zitat Arem R, Zoghbi W (1985) Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine (Baltimore) 64:323–332 Arem R, Zoghbi W (1985) Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine (Baltimore) 64:323–332
18.
Zurück zum Zitat Walfish PG, Feig DS, Bauman WA (1987) Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay. J Endocrinol Invest 10:601–604PubMed Walfish PG, Feig DS, Bauman WA (1987) Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay. J Endocrinol Invest 10:601–604PubMed
19.
Zurück zum Zitat Grunberger G, Weiner JL, Silverman R, Taylor S, Gorden P (1988) Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med 108:252–257PubMed Grunberger G, Weiner JL, Silverman R, Taylor S, Gorden P (1988) Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med 108:252–257PubMed
20.
Zurück zum Zitat Kaminer Y, Robbins DR (1988) Attempted suicide by insulin overdose in insulin-dependent diabetic adolescents. Pediatrics 81:526–528PubMed Kaminer Y, Robbins DR (1988) Attempted suicide by insulin overdose in insulin-dependent diabetic adolescents. Pediatrics 81:526–528PubMed
21.
Zurück zum Zitat Lebowitz MR, Blumenthal SA (1993) The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med 153:650–655PubMed Lebowitz MR, Blumenthal SA (1993) The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med 153:650–655PubMed
22.
Zurück zum Zitat Patel F (1995) Successful suicide by insulin injection in a non-diabetic. Med Sci Law 35:181–182PubMed Patel F (1995) Successful suicide by insulin injection in a non-diabetic. Med Sci Law 35:181–182PubMed
23.
Zurück zum Zitat Waickus CM, de Bustros A, Shakil A (1999) Recognizing factitious hypoglycemia in the family practice setting. J Am Board Fam Pract 12:133–136PubMed Waickus CM, de Bustros A, Shakil A (1999) Recognizing factitious hypoglycemia in the family practice setting. J Am Board Fam Pract 12:133–136PubMed
24.
Zurück zum Zitat Giordano BP, Rainwater NG (1986) Factitious hypoglycemia: case report. Diabetes Educ 12:37–39PubMed Giordano BP, Rainwater NG (1986) Factitious hypoglycemia: case report. Diabetes Educ 12:37–39PubMed
25.
Zurück zum Zitat Colsky LC, Campo AE, Gonzalez-Blanco M (1985) Insulin and the suicidal patient. West J Med 143:679PubMed Colsky LC, Campo AE, Gonzalez-Blanco M (1985) Insulin and the suicidal patient. West J Med 143:679PubMed
26.
Zurück zum Zitat Critchley JA, Proudfoot AT, Boyd SG, Campbell IW, Brown NS, Gordon A (1984) Deaths and paradoxes after intentional insulin overdosage. Br Med J (Clin Res Ed) 289:225 Critchley JA, Proudfoot AT, Boyd SG, Campbell IW, Brown NS, Gordon A (1984) Deaths and paradoxes after intentional insulin overdosage. Br Med J (Clin Res Ed) 289:225
27.
Zurück zum Zitat Cooper AJ (1994) Attempted suicide using insulin by a non diabetic: a case study demonstrating the acute and chronic consequences of profound hypoglycemia. Can J Psychiatry 39:103–107PubMed Cooper AJ (1994) Attempted suicide using insulin by a non diabetic: a case study demonstrating the acute and chronic consequences of profound hypoglycemia. Can J Psychiatry 39:103–107PubMed
28.
Zurück zum Zitat Megarbane B, Deye BV, Sonneville R, Collet C, Launay JM, Baud FJ (2007) Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care 11:R115PubMed Megarbane B, Deye BV, Sonneville R, Collet C, Launay JM, Baud FJ (2007) Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care 11:R115PubMed
29.
Zurück zum Zitat von Mach MA, Meyer S, Omogbehin B, Kann PH, Weilemann LS (2004) Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther 42:277–280 von Mach MA, Meyer S, Omogbehin B, Kann PH, Weilemann LS (2004) Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther 42:277–280
30.
31.
32.
Zurück zum Zitat Lindquist O, Rammer L (1975) Insulin in post-mortem blood. Z Rechtsmed 75:275–277PubMed Lindquist O, Rammer L (1975) Insulin in post-mortem blood. Z Rechtsmed 75:275–277PubMed
33.
Zurück zum Zitat Kernbach-Wighton G, Puschel K (1998) On the phenomenology of lethal applications of insulin. Forensic Sci Int 93:61–73PubMed Kernbach-Wighton G, Puschel K (1998) On the phenomenology of lethal applications of insulin. Forensic Sci Int 93:61–73PubMed
34.
Zurück zum Zitat Ferner RE, Neil HA (1988) Sulphonylureas and hypoglycaemia. Br Med J (Clin Res Ed) 296:949–950 Ferner RE, Neil HA (1988) Sulphonylureas and hypoglycaemia. Br Med J (Clin Res Ed) 296:949–950
35.
Zurück zum Zitat Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in Type 2 diabetes. Diabet Med 25:245–254PubMed Amiel SA, Dixon T, Mann R, Jameson K (2008) Hypoglycaemia in Type 2 diabetes. Diabet Med 25:245–254PubMed
36.
Zurück zum Zitat Holstein A, Plaschke A, Egberts EH (2001) Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 17:467–473PubMed Holstein A, Plaschke A, Egberts EH (2001) Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 17:467–473PubMed
37.
Zurück zum Zitat Holstein A, Plaschke A, Hammer C, Egberts EH (2003) Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 59:91–97PubMed Holstein A, Plaschke A, Hammer C, Egberts EH (2003) Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 59:91–97PubMed
38.
Zurück zum Zitat Asplund K, Wiholm BE, Lithner F (1983) Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 24:412–417PubMed Asplund K, Wiholm BE, Lithner F (1983) Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 24:412–417PubMed
39.
Zurück zum Zitat Wark G (2009) How to look for insulin etc. SAS Peptide Hormone Section, RSCH. Guildford Peptide Hormones Scheme Wark G (2009) How to look for insulin etc. SAS Peptide Hormone Section, RSCH. Guildford Peptide Hormones Scheme
40.
Zurück zum Zitat Nakayama S, Hirose T, Watada H, Tanaka Y, Kawamori R (2005) Hypoglycemia following a nateglinide overdose in a suicide attempt. Diab Care 28:227–228 Nakayama S, Hirose T, Watada H, Tanaka Y, Kawamori R (2005) Hypoglycemia following a nateglinide overdose in a suicide attempt. Diab Care 28:227–228
41.
Zurück zum Zitat Winter WE (1999) Evaluation of hypoglycemia and hyperglycemia. In: Jialal I, Winter WE, Chan DW (eds) Handbook of diagnostic endocrinology. AACC, Washington, pp 157–158 Winter WE (1999) Evaluation of hypoglycemia and hyperglycemia. In: Jialal I, Winter WE, Chan DW (eds) Handbook of diagnostic endocrinology. AACC, Washington, pp 157–158
42.
Zurück zum Zitat Young DS (2000) Effects of Drugs on Clinical Laboratoty tests. Vol. 1.Washington. AACC Press 3:349–371 Young DS (2000) Effects of Drugs on Clinical Laboratoty tests. Vol. 1.Washington. AACC Press 3:349–371
43.
Zurück zum Zitat Lund E, Wamberg E (1964) Phenylketonuria. A review with special reference to diagnostic methods. Ugeskr Laeger 126:497–505PubMed Lund E, Wamberg E (1964) Phenylketonuria. A review with special reference to diagnostic methods. Ugeskr Laeger 126:497–505PubMed
44.
Zurück zum Zitat Coe JI (1977) Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu 1976:55–92PubMed Coe JI (1977) Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu 1976:55–92PubMed
45.
Zurück zum Zitat Forrest AR (1993) ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol 46:292–296PubMed Forrest AR (1993) ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol 46:292–296PubMed
46.
Zurück zum Zitat Gormsen H, Lund A (1985) The diagnostic value of postmortem blood glucose determinations in cases of diabetes mellitus. Forensic Sci Int 28:103–107PubMed Gormsen H, Lund A (1985) The diagnostic value of postmortem blood glucose determinations in cases of diabetes mellitus. Forensic Sci Int 28:103–107PubMed
47.
Zurück zum Zitat Sturner WQ, Gantner GE Jr (1964) Postmortem vitreous glucose determinations. J Forensic Sci 9:485–491PubMed Sturner WQ, Gantner GE Jr (1964) Postmortem vitreous glucose determinations. J Forensic Sci 9:485–491PubMed
48.
Zurück zum Zitat Coe JI (1969) Postmortem chemistries on human vitreous humor. Am J Clin Pathol 51:741–750PubMed Coe JI (1969) Postmortem chemistries on human vitreous humor. Am J Clin Pathol 51:741–750PubMed
49.
Zurück zum Zitat Bray M, Luke JL, Blackbourne BD (1983) Vitreous humor chemistry in deaths associated with rapid chilling and prolonged freshwater immersion. J Forensic Sci 28:588–593PubMed Bray M, Luke JL, Blackbourne BD (1983) Vitreous humor chemistry in deaths associated with rapid chilling and prolonged freshwater immersion. J Forensic Sci 28:588–593PubMed
50.
Zurück zum Zitat Bray M (1984) The eye as a chemical indicator of environmental temperature at the time of death. J Forensic Sci 29:396–403PubMed Bray M (1984) The eye as a chemical indicator of environmental temperature at the time of death. J Forensic Sci 29:396–403PubMed
51.
Zurück zum Zitat Bray M (1984) The effect of chilling, freezing, and rewarming on the postmortem chemistry of vitreous humor. J Forensic Sci 29:404–411PubMed Bray M (1984) The effect of chilling, freezing, and rewarming on the postmortem chemistry of vitreous humor. J Forensic Sci 29:404–411PubMed
52.
Zurück zum Zitat Kernbach G, Puschel K, Brinkmann B (1986) Biochemical measurements of glucose metabolism in relation to cause of death and postmortem effects. Z Rechtsmed 96:199–213PubMed Kernbach G, Puschel K, Brinkmann B (1986) Biochemical measurements of glucose metabolism in relation to cause of death and postmortem effects. Z Rechtsmed 96:199–213PubMed
53.
Zurück zum Zitat Traub F (1969) Methode zur Erkennung von tödlichen Zuckerstoffwechselstörungen an der Leiche (Diabetes mellitus und Hypoglykämie). Zbl Allg Path Path Anat 112:390–399 Traub F (1969) Methode zur Erkennung von tödlichen Zuckerstoffwechselstörungen an der Leiche (Diabetes mellitus und Hypoglykämie). Zbl Allg Path Path Anat 112:390–399
54.
Zurück zum Zitat Coe JI (1977) Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu 1976:55–92PubMed Coe JI (1977) Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg Med Annu 1976:55–92PubMed
55.
Zurück zum Zitat Kernbach G, Puschel K, Brinkmann B (1986) Biochemical measurements of glucose metabolism in relation to cause of death and postmortem effects. Z Rechtsmed 96:199–213PubMed Kernbach G, Puschel K, Brinkmann B (1986) Biochemical measurements of glucose metabolism in relation to cause of death and postmortem effects. Z Rechtsmed 96:199–213PubMed
56.
Zurück zum Zitat Osuna E, Garcia-Villora A, Perez-Carceles M, Conejero J, Maria Abenza J, Martinez P, Luna A (2001) Glucose and lactate in vitreous humor compared with the determination of fructosamine for the postmortem diagnosis of diabetes mellitus. Am J Forensic Med Pathol 22:244–249PubMed Osuna E, Garcia-Villora A, Perez-Carceles M, Conejero J, Maria Abenza J, Martinez P, Luna A (2001) Glucose and lactate in vitreous humor compared with the determination of fructosamine for the postmortem diagnosis of diabetes mellitus. Am J Forensic Med Pathol 22:244–249PubMed
57.
Zurück zum Zitat Osuna E, Garcia-Villora A, Perez-Carceles MD, Conejero J, Abenza JM, Martinez P, Luna A (1999) Vitreous humor fructosamine concentrations in the autopsy diagnosis of diabetes mellitus. Int J Legal Med 112:275–279PubMed Osuna E, Garcia-Villora A, Perez-Carceles MD, Conejero J, Abenza JM, Martinez P, Luna A (1999) Vitreous humor fructosamine concentrations in the autopsy diagnosis of diabetes mellitus. Int J Legal Med 112:275–279PubMed
58.
Zurück zum Zitat Vivero G, Vivero-Salmeron G, Perez Carceles Bedate A, Luna A, Osuna E (2008) Combined determination of glucose and fructosamine in vitreous humor as a post-mortem tool to identify antemortem hyperglycemia. Rev Diabet Stud 5:220–224PubMed Vivero G, Vivero-Salmeron G, Perez Carceles Bedate A, Luna A, Osuna E (2008) Combined determination of glucose and fructosamine in vitreous humor as a post-mortem tool to identify antemortem hyperglycemia. Rev Diabet Stud 5:220–224PubMed
59.
Zurück zum Zitat Gressner A, Arndt T (2006) Lexikon der Medizinischen Laboratoriumsdiagnostik. Band 1: Klinische Chemie. Springer Verlag, Berlin Gressner A, Arndt T (2006) Lexikon der Medizinischen Laboratoriumsdiagnostik. Band 1: Klinische Chemie. Springer Verlag, Berlin
60.
Zurück zum Zitat Sippel H, Mottonen M (1982) Combined glucose and lactate values in vitreous humour for postmortem diagnosis of diabetes mellitus. Forensic Sci Int 19:217–222PubMed Sippel H, Mottonen M (1982) Combined glucose and lactate values in vitreous humour for postmortem diagnosis of diabetes mellitus. Forensic Sci Int 19:217–222PubMed
61.
Zurück zum Zitat De Letter EA, Piette MH (1998) Can routinely combined analysis of glucose and lactate in vitreous humour be useful in current forensic practice? Am J Forensic Med Pathol 19:335–342PubMed De Letter EA, Piette MH (1998) Can routinely combined analysis of glucose and lactate in vitreous humour be useful in current forensic practice? Am J Forensic Med Pathol 19:335–342PubMed
62.
Zurück zum Zitat Peretz DI, McGregor M, Dossetor JB (1964) Lactatacidosis: a clinically significant aspect of shock. Can Med Assoc J 90:673–5PubMed Peretz DI, McGregor M, Dossetor JB (1964) Lactatacidosis: a clinically significant aspect of shock. Can Med Assoc J 90:673–5PubMed
63.
Zurück zum Zitat Kleine TO, Baerlocher K, Niederer V, Keller H, Reutter F, Tritschler W, Bablok W (1979) Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl). Dtsch Med Wochenschr 104:553–557PubMed Kleine TO, Baerlocher K, Niederer V, Keller H, Reutter F, Tritschler W, Bablok W (1979) Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl). Dtsch Med Wochenschr 104:553–557PubMed
64.
Zurück zum Zitat Hindle EJ, Rostron GM, Gatt JA (1985) The diagnostic value of glycated haemoglobin levels in post-mortem blood. Ann Clin Biochem 22:144–147PubMed Hindle EJ, Rostron GM, Gatt JA (1985) The diagnostic value of glycated haemoglobin levels in post-mortem blood. Ann Clin Biochem 22:144–147PubMed
65.
Zurück zum Zitat Astles R, Williams CP, Sedor F (1994) Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin Chem 40:1327–1330PubMed Astles R, Williams CP, Sedor F (1994) Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin Chem 40:1327–1330PubMed
66.
Zurück zum Zitat Liss E, Bechtel S (1990) Improvement of glucose preservation in blood samples. J Clin Chem Clin Biochem 28:689–690PubMed Liss E, Bechtel S (1990) Improvement of glucose preservation in blood samples. J Clin Chem Clin Biochem 28:689–690PubMed
67.
Zurück zum Zitat Rick W (1977) Klinische Chemie und Mikroskopie, 5th edn. Springer Verlag, Berlin Rick W (1977) Klinische Chemie und Mikroskopie, 5th edn. Springer Verlag, Berlin
68.
Zurück zum Zitat Müller B (2005) In: Madea B, Musshoff F (eds) Rechtsmedizin. Springer Verlag, Berlin Müller B (2005) In: Madea B, Musshoff F (eds) Rechtsmedizin. Springer Verlag, Berlin
69.
Zurück zum Zitat Bunn HF (1981) Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 70:325–330PubMed Bunn HF (1981) Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 70:325–330PubMed
70.
Zurück zum Zitat Svendsen PA, Lauritzen T, Soegaard U, Nerup J (1982) Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia 23:403–405PubMed Svendsen PA, Lauritzen T, Soegaard U, Nerup J (1982) Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia 23:403–405PubMed
71.
Zurück zum Zitat Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ (2008) Translating the A1C assay into estimated average glucose values. Diab Care 31:1473–1478 Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ (2008) Translating the A1C assay into estimated average glucose values. Diab Care 31:1473–1478
72.
Zurück zum Zitat The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, the International Diabetes Federation (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diab Care 30:2399–2400 The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, the International Diabetes Federation (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diab Care 30:2399–2400
73.
Zurück zum Zitat Nordin G, Dybkaer R (2007) Recommendation for term and measurement unit for "HbA1c". Clin Chem Lab Med 45:1081–1082PubMed Nordin G, Dybkaer R (2007) Recommendation for term and measurement unit for "HbA1c". Clin Chem Lab Med 45:1081–1082PubMed
74.
Zurück zum Zitat Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB (2004) Tests of glycemia in diabetes. Diab Care 27:1761–1773 Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB (2004) Tests of glycemia in diabetes. Diab Care 27:1761–1773
75.
Zurück zum Zitat Goldstein DE, Walker B, Rawlings SS, Hess RL, England JD, Peth SB, Hewett JE (1980) Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Diab Care 3:503–507 Goldstein DE, Walker B, Rawlings SS, Hess RL, England JD, Peth SB, Hewett JE (1980) Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Diab Care 3:503–507
76.
Zurück zum Zitat Chen C, Glagov S, Mako M, Rochman H, Rubenstein AH (1983) Post-mortem glycosylated hemoglobin (HbA1c): evidence for a history of diabetes mellitus. Ann Clin Lab Sci 13:407–410PubMed Chen C, Glagov S, Mako M, Rochman H, Rubenstein AH (1983) Post-mortem glycosylated hemoglobin (HbA1c): evidence for a history of diabetes mellitus. Ann Clin Lab Sci 13:407–410PubMed
77.
Zurück zum Zitat Kernbach G, Brinkmann B (1983) Postmortem pathochemistry for the determination of the cause of death in diabetic coma. Pathologe 4:235–240PubMed Kernbach G, Brinkmann B (1983) Postmortem pathochemistry for the determination of the cause of death in diabetic coma. Pathologe 4:235–240PubMed
78.
Zurück zum Zitat Uemura K, Shintani-Ishida K, Saka NM, Ikegaya H, Kikuchi Y, Yoshida K (2008) Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Leg Med 15:312–317PubMed Uemura K, Shintani-Ishida K, Saka NM, Ikegaya H, Kikuchi Y, Yoshida K (2008) Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Leg Med 15:312–317PubMed
79.
Zurück zum Zitat Goulle JP, Lacroix C, Bouige D (2002) Glycated hemoglobin: a useful post-mortem reference marker in determining diabetes. Forensic Sci Int 128:44–49PubMed Goulle JP, Lacroix C, Bouige D (2002) Glycated hemoglobin: a useful post-mortem reference marker in determining diabetes. Forensic Sci Int 128:44–49PubMed
80.
Zurück zum Zitat Winecker RE, Hammett-Stabler CA, Chapman JF, Ropero-Miller JD (2002) HbA1c as a postmortem tool to identify glycemic control. J Forensic Sci 47:1373–1379PubMed Winecker RE, Hammett-Stabler CA, Chapman JF, Ropero-Miller JD (2002) HbA1c as a postmortem tool to identify glycemic control. J Forensic Sci 47:1373–1379PubMed
81.
Zurück zum Zitat Kobold U, Jeppsson JO, Dulffer T, Finke A, Hoelzel W, Miedema K (1997) Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 43:1944–1951PubMed Kobold U, Jeppsson JO, Dulffer T, Finke A, Hoelzel W, Miedema K (1997) Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 43:1944–1951PubMed
82.
Zurück zum Zitat Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40:78–89PubMed Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40:78–89PubMed
83.
Zurück zum Zitat Lapolla A, Fedele D, Traldi P (2001) Diabetes and mass spectrometry. Diabetes Metab Res Rev 17:99–112PubMed Lapolla A, Fedele D, Traldi P (2001) Diabetes and mass spectrometry. Diabetes Metab Res Rev 17:99–112PubMed
84.
Zurück zum Zitat Tahara Y, Shima K (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diab Care 18:440–447 Tahara Y, Shima K (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diab Care 18:440–447
85.
Zurück zum Zitat Johnson RN, Metcalf PA, Baker J (1983) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127:87–95PubMed Johnson RN, Metcalf PA, Baker J (1983) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127:87–95PubMed
86.
Zurück zum Zitat Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM (1995) Tests of glycemia in diabetes. Diab Care 18:896–909 Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM (1995) Tests of glycemia in diabetes. Diab Care 18:896–909
87.
Zurück zum Zitat Hill RP, Hindle EJ, Howey JE, Lemon M, Lloyd DR (1990) Recommendations for adopting standard conditions and analytical procedures in the measurement of serum fructosamine concentration. Ann Clin Biochem 27:413–424PubMed Hill RP, Hindle EJ, Howey JE, Lemon M, Lloyd DR (1990) Recommendations for adopting standard conditions and analytical procedures in the measurement of serum fructosamine concentration. Ann Clin Biochem 27:413–424PubMed
88.
Zurück zum Zitat Cohen MP (1992) Perspective: measurement of circulating glycated proteins to monitor intermediate-term changes in glycaemic control. Eur J Clin Chem Clin Biochem 30:851–859PubMed Cohen MP (1992) Perspective: measurement of circulating glycated proteins to monitor intermediate-term changes in glycaemic control. Eur J Clin Chem Clin Biochem 30:851–859PubMed
89.
Zurück zum Zitat Lloyd DR, Nott M, Marples J (1985) Comparison of serum fructosamine with glycosylated serum protein (determined by affinity chromatography) for the assessment of diabetic control. Diabet Med 2:474–478PubMed Lloyd DR, Nott M, Marples J (1985) Comparison of serum fructosamine with glycosylated serum protein (determined by affinity chromatography) for the assessment of diabetic control. Diabet Med 2:474–478PubMed
90.
Zurück zum Zitat Gordon A, Glaser B, Wald M, Del Rio G, Della Casa L, Gross J, Cerasi E (1992) Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients. Diab Care 15:645–650 Gordon A, Glaser B, Wald M, Del Rio G, Della Casa L, Gross J, Cerasi E (1992) Glycosylated serum protein levels assayed with highly sensitive immunoradiometric assay accurately reflect glycemic control of diabetic patients. Diab Care 15:645–650
91.
Zurück zum Zitat Baker J, Reid I, Holdaway I (1985) Serum fructosamine in patients with diabetes mellitus. N Z Med J 98:532–535PubMed Baker J, Reid I, Holdaway I (1985) Serum fructosamine in patients with diabetes mellitus. N Z Med J 98:532–535PubMed
92.
Zurück zum Zitat Lemon M, Forrest AR (1986) Fructosamine activity of proteins in serum. Clin Chem 32:2101PubMed Lemon M, Forrest AR (1986) Fructosamine activity of proteins in serum. Clin Chem 32:2101PubMed
93.
Zurück zum Zitat Koskinen P, Irjala K (1988) Stability of serum fructosamine during storage. Clin Chem 34:2545–2546PubMed Koskinen P, Irjala K (1988) Stability of serum fructosamine during storage. Clin Chem 34:2545–2546PubMed
94.
Zurück zum Zitat Ritz S, Mehlan G, Martz W (1996) Postmortem diagnosis of diabetic metabolic derangement: elevated alpha 1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemia. J Forensic Sci 41:94–100PubMed Ritz S, Mehlan G, Martz W (1996) Postmortem diagnosis of diabetic metabolic derangement: elevated alpha 1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemia. J Forensic Sci 41:94–100PubMed
95.
Zurück zum Zitat Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS (1993) Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 76:752–756PubMed Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS (1993) Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 76:752–756PubMed
96.
Zurück zum Zitat Gordon MR, Flockhart D, Zawadzki JK, Taylor T, Ramey JN, Eastman RC (1988) Hypoglycemia due to inadvertent dispensing of chlorpropamide. Am J Med 85:271–272PubMed Gordon MR, Flockhart D, Zawadzki JK, Taylor T, Ramey JN, Eastman RC (1988) Hypoglycemia due to inadvertent dispensing of chlorpropamide. Am J Med 85:271–272PubMed
97.
Zurück zum Zitat Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474PubMed Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474PubMed
99.
Zurück zum Zitat Mutschler E, Geisslinger G, Kroemer HK, Schäfer-Korting M (2001) Arzneimittelwirkungen, Lehrbuch der Pharmakologie und Toxikologie, 8th edn. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart Mutschler E, Geisslinger G, Kroemer HK, Schäfer-Korting M (2001) Arzneimittelwirkungen, Lehrbuch der Pharmakologie und Toxikologie, 8th edn. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart
100.
Zurück zum Zitat Ho EN, Yiu KC, Wan TS, Stewart BD, Watkins KL (2004) Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 811:65–73PubMed Ho EN, Yiu KC, Wan TS, Stewart BD, Watkins KL (2004) Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 811:65–73PubMed
101.
Zurück zum Zitat Thevis M, Geyer H, Schanzer W (2005) Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry - a matter for doping control analysis. Rapid Commun Mass Spectrom 19:928–936PubMed Thevis M, Geyer H, Schanzer W (2005) Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry - a matter for doping control analysis. Rapid Commun Mass Spectrom 19:928–936PubMed
102.
Zurück zum Zitat Hess C, Musshoff F, Madea B (2010) Identification and validated quantification of oral hypoglycaemic drugs in plasma byelectrospray ionisation liquid chromatography – mass spectrometry. Submitted July 2010 Hess C, Musshoff F, Madea B (2010) Identification and validated quantification of oral hypoglycaemic drugs in plasma byelectrospray ionisation liquid chromatography – mass spectrometry. Submitted July 2010
103.
Zurück zum Zitat Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436–472PubMed Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436–472PubMed
104.
Zurück zum Zitat Chevenne D, Trivin F, Porquet D (1999) Insulin assays and reference values. Diabetes Metab 25:459–476PubMed Chevenne D, Trivin F, Porquet D (1999) Insulin assays and reference values. Diabetes Metab 25:459–476PubMed
105.
Zurück zum Zitat Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2004) Hyperglycemic crises in diabetes. Diab Care 27(Suppl 1):S94–102 Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2004) Hyperglycemic crises in diabetes. Diab Care 27(Suppl 1):S94–102
106.
Zurück zum Zitat Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N (2006) Overview of the diagnosis and management of diabetic ketoacidosis. Am J Med Sci 331:243–251PubMed Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N (2006) Overview of the diagnosis and management of diabetic ketoacidosis. Am J Med Sci 331:243–251PubMed
107.
Zurück zum Zitat Kaufman FR, Halvorson M (1999) The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 28:576–582PubMed Kaufman FR, Halvorson M (1999) The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 28:576–582PubMed
108.
Zurück zum Zitat Faich GA, Fishbein HA, Ellis SE (1983) The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 117:551–558PubMed Faich GA, Fishbein HA, Ellis SE (1983) The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 117:551–558PubMed
109.
Zurück zum Zitat UK Prospective Diabetes Study Group (UKPDS) (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 UK Prospective Diabetes Study Group (UKPDS) (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
110.
Zurück zum Zitat Standards of medical care in diabetes (2006) Diab Care 29(Suppl 1):S4–42 Standards of medical care in diabetes (2006) Diab Care 29(Suppl 1):S4–42
111.
Zurück zum Zitat Gouni-Berthold I, Krone W (2006) Diabetic ketoacidosis and hyperosmolar hyperglycemic state. Med Klin (Munich) 101(Suppl 1):100–105 Gouni-Berthold I, Krone W (2006) Diabetic ketoacidosis and hyperosmolar hyperglycemic state. Med Klin (Munich) 101(Suppl 1):100–105
112.
Zurück zum Zitat Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2001) Management of hyperglycemic crises in patients with diabetes. Diab Care 24:131–153 Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2001) Management of hyperglycemic crises in patients with diabetes. Diab Care 24:131–153
113.
Zurück zum Zitat Foster (1995) Diabetes mellitus. In: Schmailzl KJG (ed) Harrisons Innere Medizin 2, 13th edn. Blackwell, Berlin Vienna Oxford, pp 2314–2338 Foster (1995) Diabetes mellitus. In: Schmailzl KJG (ed) Harrisons Innere Medizin 2, 13th edn. Blackwell, Berlin Vienna Oxford, pp 2314–2338
114.
Zurück zum Zitat Radermacher L, D'Orio V (2005) Metabolic emergencies related to diabetes mellitus: ketoacidosis and hyperosmolar state. Rev Méd Liège 60:466–471PubMed Radermacher L, D'Orio V (2005) Metabolic emergencies related to diabetes mellitus: ketoacidosis and hyperosmolar state. Rev Méd Liège 60:466–471PubMed
115.
Zurück zum Zitat Fishbein H, Palumbo PJ (1995) Acute metabolic complications in diabetes. In: National Diabetes Data Group. Diabetes in America. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. pp 283–291 Fishbein H, Palumbo PJ (1995) Acute metabolic complications in diabetes. In: National Diabetes Data Group. Diabetes in America. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. pp 283–291
116.
Zurück zum Zitat Kadis P, Balazic J, Ferlan-Marolt V (1999) Alcoholic ketoacidosis: a cause of sudden death of chronic alcoholics. Forensic Sci Int 103:S53–S59 Kadis P, Balazic J, Ferlan-Marolt V (1999) Alcoholic ketoacidosis: a cause of sudden death of chronic alcoholics. Forensic Sci Int 103:S53–S59
117.
Zurück zum Zitat Nilsson A, Tideholm B, Kalen J, Katzman P (1988) Incidence of severe hypoglycemia and its causes in insulin-treated diabetics. Acta Med Scand 224:257–262PubMed Nilsson A, Tideholm B, Kalen J, Katzman P (1988) Incidence of severe hypoglycemia and its causes in insulin-treated diabetics. Acta Med Scand 224:257–262PubMed
118.
Zurück zum Zitat The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450–459 The DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450–459
119.
Zurück zum Zitat Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781PubMed Schwartz NS, Clutter WE, Shah SD, Cryer PE (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781PubMed
120.
Zurück zum Zitat Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67–E74PubMed Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67–E74PubMed
121.
Zurück zum Zitat Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797–807PubMed Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797–807PubMed
122.
Zurück zum Zitat Marks V (2006) Hypoglycaemia: insulin and conflicts with the law. Br J Diabetes Vasc Dis 6:281–285 Marks V (2006) Hypoglycaemia: insulin and conflicts with the law. Br J Diabetes Vasc Dis 6:281–285
123.
Zurück zum Zitat Coe JI (1974) Postmortem chemistry: practical considerations and a review of the literature. J Forensic Sci 19:13–32PubMed Coe JI (1974) Postmortem chemistry: practical considerations and a review of the literature. J Forensic Sci 19:13–32PubMed
124.
Zurück zum Zitat Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14:91–117PubMed Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14:91–117PubMed
125.
Zurück zum Zitat Forrest AR (1993) ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol 46:292–296PubMed Forrest AR (1993) ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol 46:292–296PubMed
126.
Zurück zum Zitat Sturner WQ, Gantner GE Jr (1964) Postmortem vitreous glucose determinations. J Forensic Sci 9:485–491PubMed Sturner WQ, Gantner GE Jr (1964) Postmortem vitreous glucose determinations. J Forensic Sci 9:485–491PubMed
127.
Zurück zum Zitat Peclet C, Picotte P, Jobin F (1994) The use of vitreous humor levels of glucose, lactic acid and blood levels of acetone to establish antemortem hyperglycemia in diabetics. Forensic Sci Int 65:1–6PubMed Peclet C, Picotte P, Jobin F (1994) The use of vitreous humor levels of glucose, lactic acid and blood levels of acetone to establish antemortem hyperglycemia in diabetics. Forensic Sci Int 65:1–6PubMed
128.
Zurück zum Zitat Leahy MS, Farber ER (1967) Postmortem chemistry of human vitreous humor. J Forensic Sci 12:214–222PubMed Leahy MS, Farber ER (1967) Postmortem chemistry of human vitreous humor. J Forensic Sci 12:214–222PubMed
129.
Zurück zum Zitat Karlovsek M (2004) Diagnostic values of combined glucose and lactate values in cerebrospinal fluid and vitreous humour - our experiences. Forensic Sci Int 146(Suppl):S19–23PubMed Karlovsek M (2004) Diagnostic values of combined glucose and lactate values in cerebrospinal fluid and vitreous humour - our experiences. Forensic Sci Int 146(Suppl):S19–23PubMed
130.
Zurück zum Zitat Ritz S, Kaatsch HJ (1990) Postmortem diagnosis of fatal diabetic metabolic dyscontrol: what is the significance of cerebrospinal fluid and vitreous body total values and HbA1? Pathologe 11:158–165PubMed Ritz S, Kaatsch HJ (1990) Postmortem diagnosis of fatal diabetic metabolic dyscontrol: what is the significance of cerebrospinal fluid and vitreous body total values and HbA1? Pathologe 11:158–165PubMed
131.
Zurück zum Zitat Kugler J, Oehmichen M (1986) Studies of glucose metabolism in the cadaver. Beitr Gerichtl Med 44:185–8PubMed Kugler J, Oehmichen M (1986) Studies of glucose metabolism in the cadaver. Beitr Gerichtl Med 44:185–8PubMed
Metadaten
Titel
Disorders of glucose metabolism–post mortem analyses in forensic cases: part I
verfasst von
Cornelius Hess
Frank Musshoff
Burkhard Madea
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2011
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-010-0509-6

Weitere Artikel der Ausgabe 2/2011

International Journal of Legal Medicine 2/2011 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin